Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PTBaileyon Sep 17, 2021 11:42am
70 Views
Post# 33877537

RE:RE:RE:Calm Down

RE:RE:RE:Calm Down
Dude51 wrote: PTBailey please read the article before you defend mgmt.
https://claritasinvestors.com/ Read the article by the invester dude, if Drew assole has not pulled it. It's the kind dicck move he would do. He banned me for speaking my mind on this site. I had no warnings or anything, just dropped me because of what I said about the bs at class on Stock house. That's a dicck move imo. Hey Drew no comeback? I know you read this site, remember that's why you banned me from your site.

No comments, dicck head? 


Can't really add anything to your post that Amazigh hasn't already covered. 

And to echo his comments why should you be on a members only site if you have no shares in the stock. Or why are you here if you have no vested interest in the company enough that you would sell everything.

To he honest you seem to be here to vent about a personal issue you have with Drew but it is him who appears to be a adult in the room by being mature enough to not crawl in this sandbox and engage in name calling with you. 

If you are out simply move on. Your ongoing complaining isn't adding anything of value to this conversation re. CLAS. Time to move on to better things. 
<< Previous
Bullboard Posts
Next >>